革新技術

認識早期鼻咽癌篩查了解NGS技術相關研究報告

clinical papers banner

clinical papers banner

相關研究報告

Take2 Prophecy™ 早期鼻咽癌篩查所使用的技術是由屢獲殊榮的香港中文大學頂尖基因研究團隊發明。團隊曾以該技術為2萬名人士進行鼻咽癌篩查，其臨床研究結果分別於《新英格蘭醫學雜誌》以及《美國國家科學院院刊》刊登，有關詳情請瀏覽以下刊物：

Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma

Contributed by Y. M. Dennis Lo, April 26, 2018 (sent for review March 13, 2018; reviewed by Luis Diaz and Klaus Pantel)

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to screen for early nasopharyngeal carcinoma in asymptomatic persons.

網上預約
優惠碼 NEW330